Reco-Pen

Introduction

Insulin pens are modern tools used to inject insulin into the body. They are medical instruments and are one of the most popular devices among diabetics. For syringe pens, which have their own unique features in their structure and functioning.

The main representatives of the entire range are systems powered by two batteries, for example “Insupin”, and insulin systems for repeated administration of medication (so-called two-syringe systems), for example “Micro-libra”. Both systems are classified as combined continuous/bolus insulin pen delivery devices. There are also linear devices (“Insatronic”, “Evredipa”), injection pumps and system pumps (for example, Librapen XP). Each of the above systems is used to treat diabetes, as well as to control blood glucose.

Description HealSci, Inc. specializing in the production of high-precision syringes for injections, in 2018 launched a project to create a new line of syringe pens RecombiPen. As part of the project, the company conducted a series of studies to improve existing drugs through a combination of effective insulin components. The result of the research was the release of new syringe pens produced in Switzerland - Hoffmann La Roche, Germany - Roche Diagnostics. The production uses innovative MicrofineTip technology - a special mechanism for supplying insulin, characterized by maximum convenience and minimal risks during administration. Precise dosage of components is achieved by smoothly pressing the syringe handle, ensuring comfortable use in training mode. New generation pen syringes combine the best technical characteristics and advanced design to meet the needs of the modern user.

Syringes provide a high level of dosage accuracy and a low level of error. The convenient mechanism avoids insulin leakage and minimizes discomfort when administering insulin to users. Special models are designed for people with type 1 and type 2 diabetes. These syringe pens can be used to inject insulin both subcutaneously and intramuscularly.